Granahan Investment Management’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.99M | Buy |
490,613
+11,023
| +2% | +$89.7K | 0.16% | 110 |
|
|
2025
Q1 | $3.76M | Buy |
479,590
+133,497
| +39% | +$1.05M | 0.19% | 112 |
|
|
2024
Q4 | $5.15M | Sell |
346,093
-11,745
| -3% | -$175K | 0.22% | 105 |
|
|
2024
Q3 | $5.47M | Sell |
357,838
-22,009
| -6% | -$337K | 0.22% | 120 |
|
|
2024
Q2 | $5.79M | Buy |
379,847
+83,277
| +28% | +$1.27M | 0.23% | 117 |
|
|
2024
Q1 | $5.6M | Buy |
296,570
+65,793
| +29% | +$1.24M | 0.2% | 127 |
|
|
2023
Q4 | $4.41M | Buy |
230,777
+35,178
| +18% | +$672K | 0.15% | 140 |
|
|
2023
Q3 | $3.51M | Sell |
195,599
-119,237
| -38% | -$2.14M | 0.13% | 142 |
|
|
2023
Q2 | $6.39M | Sell |
314,836
-261,912
| -45% | -$5.32M | 0.2% | 120 |
|
|
2023
Q1 | $10.5M | Buy |
576,748
+166,268
| +41% | +$3.03M | 0.32% | 86 |
|
|
2022
Q4 | $8.49M | Buy |
410,480
+67,145
| +20% | +$1.39M | 0.26% | 102 |
|
|
2022
Q3 | $8.98M | Buy |
343,335
+92,950
| +37% | +$2.43M | 0.29% | 92 |
|
|
2022
Q2 | $6.35M | Buy |
250,385
+24,335
| +11% | +$617K | 0.22% | 104 |
|
|
2022
Q1 | $7.13M | Buy |
226,050
+88,663
| +65% | +$2.8M | 0.18% | 116 |
|
|
2021
Q4 | $5.56M | Buy |
137,387
+32,539
| +31% | +$1.32M | 0.11% | 144 |
|
|
2021
Q3 | $3.66M | Buy |
+104,848
| New | +$3.66M | 0.07% | 167 |
|